Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Daniel Jirak
Introduction
Daniel Jirak is a notable inventor based in Jesenice, Czech Republic. He has made significant strides in the field of medical technology, particularly in the development of antitumor compositions. His work focuses on utilizing hyaluronic acid and inorganic nanoparticles to create effective treatments for various types of cancer.
Latest Patents
Daniel Jirak holds a patent for an antitumor composition based on hydrophobized hyaluronan and inorganic nanoparticles stabilized by oleic acid. This innovative composition serves as a carrier for inorganic nanoparticles, which may include superparamagnetic nanoparticles and nanoparticles of ZnO. The composition has shown selective cytotoxicity against both suspension and adherent tumor cell lines, particularly those associated with colorectal carcinoma, lung carcinoma, hepatocellular carcinoma, and breast adenocarcinoma. The highest cytotoxic effects were observed with the composition based on an oleyl derivative of hyaluronan combined with SPIONs. Additionally, this composition can be used for in vivo detection of accumulation in the body, especially in tumors or the liver, and is sterilizable in its final package.
Career Highlights
Daniel Jirak is currently associated with Contipro A.s., a company known for its innovative approaches in biotechnology. His work has contributed to advancements in cancer treatment methodologies, showcasing his commitment to improving patient outcomes through scientific research and innovation.
Collaborations
Daniel collaborates with talented individuals such as Daniela Smejkalova and Kristina Nesporova, who contribute to the research and development efforts within his field.
Conclusion
Daniel Jirak's contributions to the field of medical technology, particularly through his patented antitumor composition, highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds the potential to significantly impact cancer treatment.